Loading company…
Neurogenetics, based in the US, is a biopharmaceutical company developing small molecule therapeutics for Alzheimer's disease.
Neurogenetics is a biopharmaceutical company developing novel small molecule therapeutics for Alzheimer's disease and related neurodegenerative disorders. It is based in the US and is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in